Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,493,527
-
Share change
-
-18,064,814
-
Total reported value
-
$4,962,788
-
Put/Call ratio
-
5.6%
-
Price per share
-
$0.17
-
Number of holders
-
98
-
Value change
-
-$4,479,204
-
Number of buys
-
33
-
Number of sells
-
52
Institutional Holders of AMPIO PHARMACEUTICALS INC - COM (AMPE) as of Q2 2022
As of 30 Jun 2022,
AMPIO PHARMACEUTICALS INC - COM (AMPE) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,493,527 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, CVA Family Office, LLC, Ergoteles LLC, CITADEL ADVISORS LLC, SRS Capital Advisors, Inc., STATE STREET CORP, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.